{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:13:06Z","timestamp":1785247986227,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"am","delay-in-days":278,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P50CA058223"],"award-info":[{"award-number":["P50CA058223"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jss.2023.08.004","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T17:48:28Z","timestamp":1693849708000},"page":"247-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy"],"prefix":"10.1016","volume":"292","author":[{"given":"Gray B.","family":"Peery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Burkbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris B.","family":"Agala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Selfridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristalyn K.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-0178","authenticated-orcid":false,"given":"Philip M.","family":"Spanheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2023.08.004_bib1","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2023.08.004_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab Emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2023.08.004_bib3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1245\/s10434-020-09073-6","article-title":"Axillary management after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer","volume":"28","author":"Kantor","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(21)00589-1","article-title":"Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjsurg.2012.10.025","article-title":"The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer","volume":"206","author":"Spanheimer","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2023.08.004_bib6","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1200\/JCO.2005.04.005","article-title":"Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the immediate preoperative anastrozole, tamoxifen, or combined with tamoxifen (IMPACT) multicenter double-blind randomized trial","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib7","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/curroncol29040179","article-title":"The clinical Impact of neoadjuvant endocrine treatment on Luminal-like breast cancers and its prognostic significance: results from a single-Institution prospective cohort study","volume":"29","author":"Mart\u00ed","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.5410","article-title":"Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: surgical results from the BrighTNess randomized clinical trial","volume":"155","author":"Golshan","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jss.2023.08.004_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SLA.0000000000001417","article-title":"Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)","volume":"262","author":"Golshan","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2023.08.004_bib10","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-a rare event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of Clipped nodes: implementation of Targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2023.08.004_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jss.2023.08.004_bib15","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jss.2023.08.004_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","article-title":"Practical considerations on the use of the charlson comorbidity index with administrative data bases","volume":"49","author":"D\u2019Hoore","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jss.2023.08.004_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clbc.2020.04.008","article-title":"Patterns of failure in women who have residual nodal disease after neoadjuvant chemotherapy for breast cancer according to extent of lymph node surgery","volume":"20","author":"Kozak","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jss.2023.08.004_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2022.11.099","article-title":"Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: a retrospective multicenter study (KROG 21-06)","volume":"49","author":"Park","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.004_bib21","doi-asserted-by":"crossref","first-page":"9056","DOI":"10.1038\/s41598-021-88442-x","article-title":"Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy","volume":"11","author":"Chun","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2023.08.004_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41523-020-00177-6","article-title":"Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer","volume":"6","author":"Kantor","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jss.2023.08.004_bib23","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1245\/s10434-019-07785-y","article-title":"Patterns of axillary management in stages 2 and 3 hormone receptor-positive breast cancer by initial treatment approach","volume":"26","author":"Weiss","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423003670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423003670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:04:04Z","timestamp":1758380644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480423003670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"alternative-id":["S0022480423003670"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2023.08.004","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2023.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}